Serum perfluorooctanoic acid (PFOA) concentrations in normal and hyperlipidemic female hamsters dosed orally with ammonium perfluorooctanoate (APFO) for up to 30 days.

about

Serum perfluorooctanoic acid (PFOA) concentrations in normal and hyperlipidemic female hamsters dosed orally with ammonium perfluorooctanoate (APFO) for up to 30 days.

Item

http://www.wikidata.org/entity/Q41680536

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Serum perfluorooctanoic acid ( ...... oate (APFO) for up to 30 days.

@en

type

Item

label

Serum perfluorooctanoic acid ( ...... oate (APFO) for up to 30 days.

@en

prefLabel

Serum perfluorooctanoic acid ( ...... oate (APFO) for up to 30 days.

@en

P1476

Serum perfluorooctanoic acid ( ...... oate (APFO) for up to 30 days.

@en

P2093

Gerald L Kennedy

http://www.w3.org/2001/XMLSchema#string

Nancy E Everds

http://www.w3.org/2001/XMLSchema#string

P2860

Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources

Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)

Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia

Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population

The C8 health project: design, methods, and participants

Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000

Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths.

Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers.

Biological monitoring of polyfluoroalkyl substances: A review.

The toxicology of perfluorooctanoate.

P304

70-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TOXREP.2015.01.013

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272240351

http://www.w3.org/2001/XMLSchema#string

P698

28962339

http://www.w3.org/2001/XMLSchema#string

P921

hyperlipidemia

P932

5598093

http://www.w3.org/2001/XMLSchema#string